Clinical Trials Browser

Phase 2 × Multiple Myeloma × tocilizumab × Clear all

NCT07589634 2026-05-15

TRI Pro

Phase 2 Not yet recruiting

Multiple Myeloma

NCT05972135 2026-04-22

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma

Phase 2 Recruiting

Cytokine Release Syndrome, Multiple Myeloma